[A15-27] Nivolumab – Benefit assessment according to §35a Social Code Book V (dossier assessment)
|2015-10-15||Dossier assessment (German version)||949 kB|
After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.
Federal Joint Committee (G-BA)
2016-01-07 G-BA decision was published.